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        Toll-like receptors (TLRs) can sense a variety 
of microbial products, such as microbial mem-
brane lipids or nucleic acids. Cell-surface TLRs, 
including TLR4/MD-2, TLR1/TLR2, and 
TLR6/TLR2, recognize microbial membrane 
lipids, whereas TLR3, TLR7, TLR8, and TLR9 
reside in intracellular organelles and recognize 
microbial nucleic acids (  1, 2  ). Immune cells such 
as DCs or macrophages express multiple TLRs, 
which are concomitantly activated in response 
to pathogens, because single microbes or viruses 
express a variety of TLR ligands. Given that mul-
tiple TLRs simultaneously respond to pathogens, 
their distribution and activation need to be 
orchestrated for optimal immune responses. 
Indeed, a synergistic relationship between TLR4/
MD-2 and TLR7/9 has been recently reported 
in the triggering of IL-12 and other Th1-pro-
moting cytokines by DCs (  3, 4  ). Dual recogni-
tion of   Mycobacterium tuberculosis   by TLR2 and 
TLR9 is required for effi   cient responses (  5  ). 
On the other hand, there is evidence that the 
collective utilization of TLRs must be limited 
to avoid excessive immune responses. For ex-
ample, overexpression of TLRs causes auto-
immunity (  6, 7  ). B cells containing the Y-linked 
autoimmune accelerator locus are intrinsically 
biased toward nucleolar antigens because of 
gene duplication and increased expression of 
TLR7. Further, autoimmunity was evident in 
mice that encode multiple copies of the TLR4 
gene (  6  ). 
  It is also of note that dedicated chaperones 
regulate the activity of specifi  c receptors (  8  –  10  ). 
Macrophages lacking the gp96 chaperone were 
hyporesponsive to a variety of TLR ligands (  11  ), 
and conversely, TLR4 signaling was positively 
enforced by artifi  cially expressing gp96 on the 
cell surface (  6  ). TLR4 as well as commensal fl  ora 
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  Immune cells express multiple Toll-like receptors (TLRs) that are concomitantly activated by 
a variety of pathogen products. Although there is presumably a need to coordinate the 
expression and function of TLRs in individual cells, little is known about the mechanisms 
governing this process. We show that a protein associated with TLR4 (PRAT4A) is required 
for multiple TLR responses. PRAT4A resides in the endoplasmic reticulum, and PRAT4A 
knockdown inhibited traffi  cking of TLR1 and TLR4 to the cell surface and ligand-induced 
traffi  cking of TLR9 to lysosomes. Other cell-surface molecules were expressed normally on 
immunocytes from PRAT4A    −  /  −    mice. There was impaired cytokine production to TLR ligands, 
except to the TLR3 ligand poly(I:C), and to whole bacteria. Activation of antigen-specifi  c T 
helper type 1 responses were also defective. Moreover, PRAT4A    −  /  −    bone marrow chimeric 
mice were resistant to lipopolysaccharide-induced sepsis. These results suggest that 
PRAT4A regulates the subcellular distribution and response of multiple TLRs and is required 
for both innate and adaptive immune responses. 2964 A MECHANISM REGULATING MULTIPLE TLRS | Takahashi et al.
  DCs lacking PRAT4A have impaired responses to a variety 
of TLR ligands 
  PRAT4A gene silencing in BM-derived DCs (BM-DCs) was 
previously shown to down-regulate cell-surface expression of 
TLR4/MD-2 and partially reduce TLR2 (  12  ). BM cells from 
PRAT4A    −  /  −    mice were indistinguishable from wild-type mice 
with regard to proliferation in the presence of GM-CSF and 
the expression of cell-surface markers such as CD11c, CD14, 
and MHC class I antigen (  Fig. 1 A  ).   In keeping with the previ-
ous results, cell-surface TLR4/MD-2 was down-regulated in 
PRAT4A    −  /  −    DCs (  Fig. 1 A  ). Partial or complete down-regula-
tion was observed in cell-surface TLR2 or the TLR-related 
molecule radioprotective 105 (RP105) (  13  ), respectively. DCs 
were then stimulated with a variety of TLR ligands, and pro-
duction of TNF-    , IL-6, IL-12, and regulated on activation, 
normal T cell expressed and secreted (RANTES) was mea-
sured by ELISA. Partial, but substantial, reduction was observed 
not only in response to a TLR4/MD-2 ligand (lipid A) but also 
to a TLR1/TLR2 ligand (Pam  3  CSK  4   [PCSK]), a TLR2/TLR6 
ligand (FSL-1), and TLR9 ligands (CpG-B or CpG-A). In 
contrast, RANTES production in response to poly(I:C) was 
not altered in PRAT4A    −  /  −    DCs (  Fig. 1 B  ). Up-regulation of 
mRNA encoding IFN-     was partially impaired in response to 
lipid A and completely impaired in response to CpG-B. No 
impairment was observed in response to poly(I:C) (  Fig. 1 C  ). 
  PRAT4A is required for TLR-mediated responses 
in macrophages and B cells 
  We next studied BM-derived macrophages (BM-macro-
phages), which were not altered with regard to cell-surface 
expression of CD14, MHC class I, or CD11b (  Fig. 2 A  ).   In 
contrast, densities of TLR4/MD-2, RP105, and TLR1 were 
all reduced (  Fig. 2 A  ). TLR2 was only slightly diminished on 
PRAT4A    −  /  −    BM-macrophages. In contrast, TLR2 was re-
ported to be undetectable on gp96    −  /  −    BM-macrophages (  11  ). 
BM-macrophages were stimulated with a variety of TLR lig-
ands, and cytokine production was determined by ELISA 
(  Fig. 2 B  ). When compared with BM-DCs, more apparent 
reduction in the production of TNF-    , IL-6, and RANTES 
was observed in response to TLR ligands. The TLR7 ligand 
loxoribine induced production of RANTES, a response com-
pletely abolished in PRAT4A    −  /  −    BM-macrophages. BM-
macrophages were similar to BM-DCs in that no impairment 
was seen in the poly(I:C)-induced production of RANTES. 
IFN-     mRNA induction in response to lipid A was partially 
impaired in PRAT4A    −  /  −    macrophages, whereas no alteration 
was seen in response to poly(I:C) (  Fig. 2 C  ). 
  Splenic B cells lacking PRAT4A were normal with regard 
to cell-surface expression of CD19, CD40, IgM, and IgD (  Fig. 3, 
A and B  ).   The absence of abnormalities in cell-surface IgM and 
IgD suggests that B cell development is normal in the absence 
of PRAT4A (  Fig. 3 B  ). In contrast, TLR2 or RP105 were 
completely or partially down-regulated, respectively (  Fig. 3 A  ). 
Splenic B cells were enriched from BM chimeric mice and 
stimulated with a variety of reagents. B cell proliferation was 
completely abolished in response to all TLR ligands with the 
cause production of anti  –  double-stranded DNA antibody 
and immune complex  –  mediated glomerulonephritis in trans-
genic mice overexpressing gp96. Despite its role as a general 
housekeeping chaperone, gp96 is unexpectedly specifi  c for 
the Toll family of receptors in macrophages. Thus, the total 
density of TLRs on immune cells can depend on a unique 
protein maturation pathway in the endoplasmic reticulum 
(ER). This would in turn limit overall TLR responsiveness 
against a pathogen and avoid hazardous immune responses. 
We now describe another global regulator of TLR availabil-
ity and show that it is rate limiting for innate and adaptive 
immune responses. 
    RESULTS   
  Generation of mice lacking a protein associated 
with TLR4 (PRAT4A) 
  We previously described the discovery of PRAT4A, which 
regulates TLR4’s surface expression and responsiveness to 
LPS (  12  ). Mice lacking PRAT4A have now been generated to 
allow rigorous assessment of its functions. A targeting vector was 
constructed to replace the fi  rst exon containing the initiation 
codon with the neomycin resistance gene (Fig. S1 A, avail-
able at http://www.jem.org/cgi/content/full/jem.20071132/DC1). 
PRAT4A    −  /  −    mice were screened by Southern hybridization 
and genomic PCR (Fig. S1 B). The PRAT4A messenger 
RNA (mRNA) and protein were not detectable in mutant 
mice homozygous for the disrupted allele (Fig. S1, C and D). 
PRAT4A    −  /  −    mice were born in less than the expected Men-
delian ratio (17 out of 156). PRAT4A    −  /  −    mice appeared nor-
mal when they were born but their growth thereafter was 
runted (Fig. S1 E), and about half of the mice (10 out of 17) 
died by the end of the weaning period. The cause of lethality 
and grow retardation was not unknown. Adjacent genes might 
have been aff  ected by the Neo promoter in the PRAT4A 
targeting vector, leading to these phenotypes. We, however, 
could not fi  nd any potential genes potentially causing growth 
retardation in the adjacent region. Given that PRAT4A has a 
chaperone activity, PRAT4A might be required for protein 
maturation of genes regulating growth such as growth hor-
mone, insulin-like growth factors, or their receptors. This pos-
sibility will be addressed in further study. 
  Despite impaired growth and premature death, the pheno-
type was much milder than in gp96-defi  cient mice, whose 
embryos do not survive beyond 5.5 d (  11  ). Thus, PRAT4A 
is unlikely to have a general housekeeping role like gp96. 
PRAT4A    −  /  −    mice at 4  –  5 wk were used for further analysis. 
We also studied BM chimeric mice to exclude the possi-
bility that impaired growth infl  uenced the immune system. 
Mice reconstituted with PRAT4A    −  /  −    BM cells were not 
  impaired in growth and survival. No diff  erences were found 
between PRAT4A    −  /  −    mice and BM chimeric mice regarding 
immune cell function. Despite the ubiquitous expression of 
PRAT4A (  12  ), PRAT4A from recipient mice did not rescue 
PRAT4A    −  /  −    hematopoietic cells, demonstrating that PRAT4A 
works in a cell-autonomous way. JEM VOL. 204, November 26, 2007 
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in response to lipid A, FSL-1, and CpG-B, and slightly im-
paired in response to PCSK (  Fig. 3 D  ). No impairment in 
CD86 up-regulation was seen in B cell responses to poly(I:C), 
anti-RP105, or anti-CD40 plus anti-IgM (  Fig. 3 D  ). Residual 
expression of RP105 seemed to be suffi   cient for partial activation 
of B cells, as revealed by CD86 up-regulation without prolif-
eration. These results demonstrated that PRAT4A is specifi  cally 
exception of poly(I:C) (  Fig. 3 C  ). Despite expression of RP105 
on the cell surface, PRAT4A    −  /  −    B cells did not proliferate in 
response to antibody-mediated RP105 ligation. In contrast, no 
impairment was observed in proliferation when secretory IgM 
and CD40 were coligated with mAbs. B cell proliferation in 
response to poly(I:C) was only marginally impaired. Up-regu-
lation of the co-stimulatory molecule CD86 was also impaired 
  Figure 1.     BM-DCs lacking PRAT4A are impaired in TLR-dependent responses. (A) Shaded histograms show the expression of TLRs and cell-surface 
markers on BM-DCs from PRAT4A  +/ −    or  PRAT4A  − / −    mice. Open histograms show control staining with the second reagent alone. (B) Bar graphs show cyto-
kine production by BM-DCs in response to a variety of TLR ligands (1 and 10 ng/ml lipid A, 100 ng/ml PCSK, 100 ng/ml FSL-1, 100 nM CpG-B, 1.5    M 
CpG-A, 150     M loxoribine, and 100     g/ml poly(I:C)). (C) Bar graphs show real-time RT-PCR analyses for mRNA encoding IFN-    , the amount of which was 
normalized by that of mRNA for     -actin. BM-DCs from BM chimeric mice were stimulated with the indicated TLR ligands, and RNA was collected 2 (lipid A) 
or 5 (CpG-B and poly(I:C)) h after stimulation, respectively. Data in B and C represent the SD.     2966 A MECHANISM REGULATING MULTIPLE TLRS | Takahashi et al.
the underlying mechanisms, we determined the subcellular 
distribution of PRAT4A. The aa sequence of PRAT4A be-
gins with a signal peptide and ends with a sequence similar to 
the ER retention signal (PDEL), suggesting its localization 
in the ER (  12  ). Mouse PRAT4A was expressed in HEK293 
cells with a Flag epitope at the C terminus and stained with 
an epitope-specifi  c mAb. PRAT4A was precisely colocalized 
required for TLR-dependent responses in BM-DCs, BM-
macrophages, and B cells. 
    N  -linked glycosylation of TLR4 is arrested in the ER 
of PRAT4A knockdown cells 
  We previously reported that PRAT4A is associated with and 
regulates cell-surface expression of TLR4 (  12  ). To explore 
  Figure 2.     PRAT4A is required for TLR responses in macrophages. (A) Shaded histograms show cell-surface expression of the indicated markers on 
BM-macrophages from PRAT4A  +/ −    or  PRAT4A  − / −    mice. Open histograms show control staining with the second reagent alone. (B) Bar graphs show cyto-
kine production by BM-macrophages in response to a variety of TLR ligands (1 and 10 ng/ml lipid A, 100 ng/ml PCSK, 100 ng/ml FSL-1, 100 nM CpG-B, 
150     M loxoribine, and 100     g/ml poly(I:C)). (C) Bar graphs show real-time RT-PCR analyses for mRNA encoding IFN-    , the amount of which was nor-
malized by that of mRNA for     -actin. BM-macrophages were stimulated with the indicated TLR ligands and RNA was collected 2 (lipid A) or 5 (poly(I:C)) h 
after stimulation, respectively. Data in B and C represent the SD.     JEM VOL. 204, November 26, 2007 
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creased by PRAT4A gene silencing (  Fig. 4 C  , compare lane 1 
with 4). We suspected that maturation of   N  -linked oligo-
saccharides might be impaired by PRAT4A knockdown. 
Immunoprecipitated TLR4 was treated with endoglycosy-
dase H (endoH), which cleaves high-mannose type   N  -linked 
oligosaccharides in the ER but is unable to cleave more ma-
ture oligosaccharides on proteins in the Golgi apparatus or on 
the cell surface. In control cells, the larger TLR4 was resistant 
to endoH, whereas the smaller TLR4 was sensitive to endoH 
treatment (  Fig. 4 C  , lane 2). In PRAT4A knockdown cells, 
with an ER marker but not with markers for the Golgi appa-
ratus or lysosomes (  Fig. 4 A  ).   When expressed in HEK293 
cells, PRAT4A was colocalized with TLR4-GFP (  Fig. 4 B  ), 
suggesting the physical association of these two molecules in 
the ER. Given that the ER is a site for protein folding and 
glycosylation, PRAT4A might have a role in the maturation/
glycosylation of TLRs. To address this issue, we conducted 
further analyses with PRAT4A knockdown cells in which 
PRAT4A mRNA was silenced by     85  –  90% (  12  ). As pub-
lished previously (  12  ), the larger species of TLR4 was de-
  Figure 3.     PRAT4A is required for TLR responses in B lymphocytes. (A) Shaded histograms show cell-surface expression of the indicated markers on 
B220-positive splenic B cells. Open histograms show control staining with the second reagent alone. (B) Dot plots show cell-surface expression of IgM 
and IgD on splenocytes. (C) Proliferation of enriched B cells stimulated with a variety of stimulation (100 and 1,000 ng/ml lipid A, 1,000 ng/ml PCSK, 
1,000 ng/ml FSL-1, 500 nM CpG-B, 100     g/ml poly(I:C), 1     g/ml anti-RP105 antibody, 1     g/ml anti-IgM antibody plus 2.25     g/ml anti-CD40 antibody). 
Splenic B cells were enriched from BM chimeric mice and stimulated for 3 d. 1    Ci  [ 3  H]thymidine was pulsed for the last 6 h, and the incorporated thymi-
dine was counted by a scintillation counter. (D) Shaded histograms show CD86 up-regulation on B cells stimulated with the indicated reagents. The con-
centration used was as described in C. Open histograms show control staining with the second reagent alone.     2968 A MECHANISM REGULATING MULTIPLE TLRS | Takahashi et al.
  Figure 4.     PRAT4A resides in the ER and is required for TLR4 protein maturation and TLR9 relocation. (A) PRAT4A-GFP was expressed in HEK293 
cells together with a marker locating ER (a), the Golgi apparatus (b), or lysosome (c). PRAT4A-GFP (green) and the markers (red) were visualized by confo-
cal microscopy. (B) TLR4-GFP and PRAT4A-FlagHis were expressed in HEK293 cells, and PRAT4A was stained with anti-Flag mAb. TLR4-GFP (green) and 
PRAT4A-FlagHis (red) were visualized by confocal microscopy. (C) Ba/F3 cells expressing TLR4  –  Flag/MD-2 were transduced with a control vector (lanes 1  –  3) 
or with a vector encoding shPRAT4A (lanes 4  –  6). Cells were subjected to immunoprecipitation with anti-Flag antibody, followed by treatment with 
buffer (N), endoH, or   N  -glycanase (N-Gly), as indicated in the fi  gure. Samples were further subjected to SDS-PAGE and immunoprobing with anti-TLR4 
mAb. Molecular masses are shown in kilodaltons. (D) B cell lymphoma M12 cells expressing TLR9-GFP plus a control vector (left) or TLR9-GFP plus 
shPRAT4A (right) were stimulated with medium (a and e) or 1     M CpG-B for 2 h (b  –  d and f  –  h). Cells were counterstained with markers for ER (a, b, e, and f) 
or lysosome (c and g) and visualized by confocal microscopy. (bottom) CpG-B conjugated with 1     M rhodamine was used for stimulation, and its distri-
bution was determined in d and h. Bars, 5   μ  m.     JEM VOL. 204, November 26, 2007 
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hemagglutinin (HA) was very weak (Fig. S3 A, available at 
http://www.jem.org/cgi/content/full/jem.20071132/DC1). 
TLR9-GFP and short hairpin RNA (shRNA) targeting 
PRAT4A (shPRAT4A) were both expressed in the M12 B 
cell line. A 75% silencing eff  ect was confi  rmed by real-time 
RT-PCR (Fig. S3 B). The TLR9-GFP protein in cells ex-
pressing shPRAT4A was still detectable by fl  ow cytometry 
(Fig. S3 C). We studied the subcellular distribution of TLR9 
in the absence of CpG-B stimulation. Given that TLR9 is an 
ER-resident protein, TLR9-GFP was compared with an ER 
marker. Colocalization of TLR9-GFP with an ER marker 
was not aff  ected by shPRAT4A (  Fig. 4 D  , a and e). Upon 
CpG-B stimulation, TLR9 was reported to redistribute from 
the ER to CpG-B DNA  –  containing lysosomes (  15, 16  ). To 
see if PRAT4A was required for ligand-induced TLR9 traf-
fi  cking, M12 cells expressing TLR9-GFP were stimulated 
with CpG-B, and the subcellular distribution of TLR9-GFP 
was studied (  Fig. 4 D  ). TLR9-GFP in control cells relocated 
out of the ER after 2 h of stimulation with CpG-B, whereas 
TLR9-GFP in M12 cells expressing shPRAT4A remained 
colocalized with an ER marker (  Fig. 4 D  , compare b with f). 
Relocated TLR9 in control M12 cells was colocalized with 
a lysosome marker and with internalized CpG-B conjugated 
with rhodamine (  Fig. 4 D  , c and d), indicating the egress of 
TLR9 from the ER and its ligand  –  receptor interaction in lyso-
somes. In sharp contrast, TLR9-GFP in M12 cells expressing 
shPRAT4A remained colocalized with an ER marker but not 
with a lysosome marker or CpG-B  –  rhodamine (  Fig. 4 D  , f  –  h). 
shPRAT4A did not infl  uence internalization of CpG-B or 
its traffi   cking to lyososmes (  Fig. 4 D  , d and h). These results 
clearly demonstrate a requirement for PRAT4A in ligand-
induced relocation of TLR9 from the ER to lysosomes. Col-
lectively with the results regarding TLR4 and TLR1, TLRs 
seem to be unable to mature in the ER or to egress from the 
ER in the absence of PRAT4A. 
  PRAT4A-independent signaling in response to lipid A 
or a lipopeptide 
  Some PRAT4A-independent responses were seen in response 
to LPS or lipopeptides, and this was particularly the case with 
BM-DCs (  Fig. 1  ). Therefore, we studied signaling events 
upon stimulation with lipid A, PCSK, or CpG-B (  Fig. 5 A  ).   
Lipid A  –  induced I    B     degradation was apparently inhibited, 
whereas IFN regulatory factor (IRF) 3 and mitogen-activated 
protein kinase phosphorylation were partially impaired in 
PRAT4A    −  /  −    BM-DCs. After PCSK stimulation, phosphory-
lation of extracellular signal-regulated kinase 1/2 and p38 
was apparently delayed, and c-Jun N-terminal kinase 1/2 
phosphorylation was impaired in PRAT4A    −  /  −    BM-DCs. 
CpG-B was distinct from these two TLR ligands in that all of 
the signaling pathways studied were completely abolished in 
PRAT4A    −  /  −    BM-DCs. TLR9 was completely dependent on 
PRAT4A, whereas TLR4 and TLR2 were still able to signal 
in the absence of PRAT4A. PRAT4A-independent lipid A 
responses were most obvious in up-regulation of the CD86 
co-stimulatory molecule. BM-DCs were induced from BM 
all of the TLR4 was sensitive to endoH treatment (  Fig. 4 C  , 
lane 5), indicating that   N  -linked oligosaccharides remained 
immature in PRAT4A knockdown cells. Thus, the matura-
tion of TLR4 is likely to be arrested in PRAT4A knock-
down cells. 
  PRAT4A is associated with TLR1 and required for its 
cell-surface expression 
  Our functional studies revealed that PRAT4A is required not 
only for TLR4-dependent responses but also for TLR2 re-
sponses (  Figs. 1  –  3  ). Cell-surface expression of TLR2 was, how-
ever, not completely abolished. TLR1, together with TLR2, 
responds to a lipopeptide, PCSK (  14  ). Cell-surface expression 
of TLR1 was very low but apparently down-regulated in 
PRAT4A    −  /  −    BM-macrophages (  Fig. 2 A  ). We suspected that 
cell-surface expression of TLR1 might be dependent on 
PRAT4A. With Ba/F3 transfectants overexpressing TLR1 
and PRAT4A, PRAT4A was found to be associated with 
TLR1 (Fig. S2 A, available at http://www.jem.org/cgi/
content/full/jem.20071132/DC1). As is the case with TLR4 
(  12  ), the smaller species of TLR1 was preferentially copre-
cipitated with PRAT4A (Fig. S2 A, lane 3). The A20 B cell 
lymphoma expresses TLR1 and TLR2 on the cell surface. 
The PRAT4A knockdown reduced cell-surface expression 
of TLR1 more eff  ectively than TLR2 (  Fig. 2 B  ). Addition-
ally, PRAT4A knockdown reduced the completely glycosy-
lated TLR1 (Fig. S2 C, compare lane 1 with 4), and all of the 
TLR1 in PRAT4A knockdown cells was sensitive to endoH 
glycosidase (Fig. S2 C, lane 5). Therefore, TLR1, like TLR4, 
is unable to mature in the ER in the absence of PRAT4A. 
Hyporesponsiveness of PRAT4A    −  /  −    cells to the PCSK TLR1/
TLR2 ligand is likely to be explained by down-regulation of 
cell-surface TLR1. We are currently studying the physical 
and functional association between PRAT4A and TLR6. 
In the previous study (  12  ), we were unable to detect phys-
ical association between PRAT4A and TLR2. Nonetheless, 
cell-surface TLR2 was diminished on PRAT4A    −  /  −    cells 
(  Figs. 1  –  3  ). We cannot exclude the possibility that PRAT4A 
is associated with TLR2. TLR2 is, however, less dependent 
on PRAT4A than TLR1, because PRAT4A gene silencing 
in the A20 B cell lymphoma had more apparent eff  ect on 
TLR1 than on TLR2 (Fig. S2 B, compare the middle and 
right columns). 
  TLR9 is unable to traffi  c to lysosomes upon ligand 
stimulation in PRAT4A knockdown cells 
  All TLR9-dependent responses were completely abolished 
in BM-DCs, BM-macrophages, and B cells from mice lack-
ing PRAT4A (  Figs. 1  –  3  ). Because TLR9 resides in the ER, 
  N  -linked oligosaccharides remain immature and are all cleaved 
by endoH treatment (  15, 16  ). TLR9 may diff  er from cell-
surface TLRs in a way requiring PRAT4A. To address a mo-
lecular mechanism by which PRAT4A controls TLR9, we 
fi  rst studied physical association between these two mole-
cules. We were able to detect PRAT4A coprecipitation with 
TLR9, whereas coprecipitation of TLR9-GFP with PRAT4A-2970 A MECHANISM REGULATING MULTIPLE TLRS | Takahashi et al.
PRAT4A knockdown and recovered by PRAT4A over-
expression (Fig. S4 B). In parallel to the results with BM-
macrophages ( Fig. 2 A ), TLR2 was not much more infl  uenced 
by PRAT4A knockdown than TLR4 in a macrophage cell 
line, RAW264.7. RAW264.7 cells were stimulated with 
TLR ligands and cytokine production was determined by 
ELISA. TNF-     production in response to TLR2/4/9 lig-
ands was down-regulated by shPRAT4A and complemented 
by PRAT4A overexpression (Fig. S4, C  –  E). TLR9 responses 
seemed more resistant to PRAT4A complementation than 
TLR2/4 responses. 
  To determine the requirement for the C-terminal se-
quence similar to the ER retention signal, we next conducted 
retrovirus-mediated complementation of PRAT4A    −  /  −    DCs. 
PRAT4A    −  /  −    BM cells that had been treated with 5-fl  uoro-
uracil (5-FU) were transduced with retroviral vector encod-
ing PRAT4A or its deletion mutants (Fig. S5 A, available at 
http://www.jem.org/cgi/content/full/jem.20071132/DC1). 
After DC induction with GM-CSF, expression of PRAT4A 
chimeric mice and stimulated with lipid A, lipopeptides, 
CpG-B, and poly(I:C). Poly(I:C) and lipid A were most po-
tent in inducing CD86 up-regulation, and no alteration was 
seen between PRAT4A  +/  −    or PRAT4A    −  /  −    cells (  Fig. 5 B  ). A 
lipopeptide (FSL-1) weakly induced CD86 up-regulation in 
both PRAT4A  +/  −    and PRAT4A    −  /  −    mice. The other lipo-
peptides, PCSK and CpG, weakly induced CD86 only in 
PRAT4A  +/  −    cells. 
  Complementation with overexpressed PRAT4A 
  To confi  rm the critical role for PRAT4A in multiple TLR 
responses, we tried to complement PRAT4A knockdown 
cells and PRAT4A    −  /  −    cells with PRAT4A overexpression. 
PRAT4A expression in RAW264.7 cells was down-regu-
lated with shPRAT4A by   >  90% (Fig. S4 A, available at 
http://www.jem.org/cgi/content/full/jem.20071132/DC1). 
Knockdown cells were further transfected with PRAT4A 
with silent mutation in the target sequence of shPRAT4A 
(mutPRAT4A). Cell-surface TLR4 was down-regulated by 
  Figure 5.     PRAT4A-independent responses in BM-DCs. (A) BM-DCs from BM chimeric mice were stimulated with lipid A, PCSK, or CpG-B, as indicated in 
the fi  gure. After the indicated periods of time, cells were lysed and subjected to SDS-PAGE, Western blotting, and immunoprobing with the indicated anti-
bodies. (B) CD86 on BM-DCs from BM chimeric mice was stained 48 h after stimulation with the indicated TLR ligands. Shaded histograms show staining with 
the second reagent alone. Histograms with continuous or dashed lines show CD86 staining of BM-DCs cultured with TLR ligands or medium, respectively.    JEM VOL. 204, November 26, 2007 
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in the circulation were measured 3 h after injection. Heat-
killed   E. coli   induced production of IL-12, IL-6, and RANTES 
in vivo, and all of the production was signifi  cantly impaired 
was examined by immunoprobing of the cell lysate with anti-
PRAT4A polyclonal antibody. We were able to detect endog-
enous PRAT4A but not the transduced PRAT4A (unpub-
lished data). Expression of the transduced PRAT4A seemed 
to be much lower than that of endogenous PRAT4A. We 
observed that the fl  ag-tagged PRAT4A was secreted into 
the culture supernatant (unpublished data). We therefore 
conducted immunoprecipitation and immunoprobing of the 
culture supernatant with antibody to the fl  ag epitope and 
were able to confirm expression of transduced PRAT4A 
(Fig. S5 B). We then looked at cell-surface expression of 
TLR2 and TLR4. DCs induced from 5-FU  –  treated BM 
were distinct from conventional BM-DCs in that cell-surface 
TLR4 was too low to detect by fl  ow cytometry (unpublished 
data). Instead, we were able to detect cell-surface TLR2 on 
PRAT4  +/+   DCs but not on PRAT4A    −  /  −    DCs (Fig. S5 C). 
Overexpression of PRAT4A complementary DNA partially 
but apparently up-regulated cell-surface TLR2 (Fig. S5 C). 
Complementation was also seen in cytokine production against 
TLR ligands (Fig. S5, D and E). Only the partial comple-
mentation seen in cell-surface expression of TLR2, TLR4-
dependent production of IL-12, and TLR9-dependent IL-6 
production was probably caused by low expression of the 
transduced PRAT4A. PRAT4A mutant lacking the puta-
tive ER retention signal PDEL (Del-1) or the C-termi-
nal 19 aa (Del-2) were both as eff  ective as the full-length 
PRAT4A in complementing cell-surface expression of TLR2 
and TLR4/9 responses (Fig. S5, C  –  E). No apparent diff  erence 
in complementation with the PRAT4A mutant was observed 
between TLR4 and TLR9 responses and between MyD88-
dependent IL-12 production and TRIF-dependent RAN-
TES production. 
  PRAT4A is required for cytokine production against bacteria 
  The results above (Figs. 1–5) have revealed that PRAT4A 
infl  uences multiple TLR responses in vitro by regulating TLR 
maturation in the ER and/or the egress from the ER.   Bacteria 
such as   Escherichia coli   have many TLR ligands, and immune 
cells such as BM-DCs, macrophages, or B cells express mul-
tiple TLRs. Given the apparent importance of PRAT4A for 
controlling the positioning and densities of multiple TLRs, 
PRAT4A    −  /  −    immune cells are likely to be compromised with 
respect to bacterial responses. To address this issue, heat-killed 
  E.coli   or   M. tuberculosis   was used for stimulating immune cells 
in vitro and in vivo. Heat-killed   E. coli   was eff  ective in in-
ducing the production of IL-6, TNF-    , IL-12, and RANTES 
in wild-type BM-DCs. All cytokine production was signifi  -
cantly impaired in PRAT4A    −  /  −    BM-DCs (  Fig. 6 A  ).   In sharp 
contrast to cytokine production, up-regulation of the CD86 
co-stimulatory molecule was unaff  ected in PRAT4A    −  /  −    DCs 
(  Fig. 6 B  ). In response to   M. tuberculosis  , cytokine   production, 
particularly of IL-6 and TNF-   , was impaired in PRAT4A    −  /  −    
BM-DCs (Fig. S6 A, available at http://www.jem.org/cgi/
content/full/jem.20071132/DC1), whereas CD86 up-regu-
lation was normal (Fig. S6 B). BM chimeric mice were next 
stimulated with heat-killed   E. coli  , and cytokine   concentrations 
  Figure 6.     PRAT4A is required for cytokine production in response to 
heat-killed     E. coli    . (A) BM-DCs from BM chimeric mice were stimulated 
with heat-killed   E. coli  , as indicated in the fi  gure. After 24 h of culture, con-
centrations of cytokines in the supernatant were determined by ELISA. Data 
represent the SD. *, P   <   0.05. (B) CD86 on BM-DCs from BM chimeric mice 
was stained 48 h after stimulation with heat-killed   E. coli  . Shaded histo-
grams show staining with the second reagent alone. Histograms with solid 
or dashed lines show CD86 staining of BM-DCs cultured with heat-killed 
  E. coli   or medium, respectively. (C) BM chimeric mice (  n   = 5) were injected 
with heat-killed   E. coli   (3.5   ×   10 8   cells per mouse) and bled 3 h after injection. 
Serum cytokines were measured by ELISA. Data represent the SD. *, P   <   0.05.    2972 A MECHANISM REGULATING MULTIPLE TLRS | Takahashi et al.
tion was profoundly impaired, whereas IgM and IgG1 were 
not impaired or only weakly impaired, respectively. These 
results demonstrated a profound defect in Th1 responses in 
PRAT4A    −  /  −    mice. 
  PRAT4A    −  /  −    mice are resistant to LPS-induced sepsis 
  To further confi  rm the physiological relevance of PRAT4A 
in in vivo innate immune responses, BM chimeric mice were 
administered a lethal dose of LPS, and the mortality was 
monitored. Although control BM chimeric mice all died 
by 4 d after LPS injection, all of the PRAT4A    −  /  −    BM chime-
ric mice survived the LPS challenge (  Fig. 8 A  ).   Sera after 
LPS injection were collected from LPS-injected mice, and 
the concentration of cytokines was determined by ELISA. 
PRAT4A    −  /  −    BM chimeric mice showed signifi  cantly lower 
production of cytokines such as TNF-    , IL-6, IL-12, and 
RANTES (  Fig. 8 B  ). 
  Given the critical role for PRAT4A in innate and acquired 
immune responses, we fi  nally addressed a possibility that 
PRAT4A might have a role in limiting excessive TLR responses 
by examining PRAT4A mRNA expression in BM-DCs after 
in PRAT4A    −  /  −    mice (  Fig. 6 C  ). Interestingly, IL-12 pro-
duction against heat-killed bacteria in vivo was more se-
verely impaired than that by BM-DCs (  Fig. 6, A and C  ). 
An important role for macrophages was   recently reported 
in in vivo IL-12 production in response bacteria (  11  ). Given 
that PRAT4A    −  /  −    macrophages were more severely impaired 
than PRAT4A    −  /  −    BM-DCs in cytokine production against 
TLR ligands (  Figs. 1 and 2  ), in vivo IL-12 production in 
response to heat-killed   E. coli   might be mainly contributed 
by macrophages. 
  A profound defect in Th1 responses in PRAT4A    −  /  −    mice 
  Impaired production of IL-12 in response to heat-killed bac-
teria suggested a defect in antigen-specifi  c adaptive immune 
responses. To address this possibility, mice were immunized 
(hind legs) with OVA mixed with CFA, which contained 
heat-killed   M. tuberculosis  . Immune responses were analyzed 
8 d after immunization. Recovered draining lymph node 
cells from PRAT4A    −  /  −    cells poorly proliferated and produced 
IFN-     in response to OVA (  Fig. 7, A and B  ).   OVA-specifi  c 
antibodies were next measured by ELISA. IgG2a/c produc-
  Figure 7.     Th1 responses are impaired in PRAT4A    −  /  −    mice. Cells from draining popliteal lymph nodes were collected from mice 8 d after immuniza-
tion (hind legs) with OVA in CFA. (A) The proliferation of antigen-specifi  c lymph node cells from PRAT4A  +/ −    or  PRAPT4A  − / −    BM chimeric mice was mea-
sured by culturing these cells with OVA for 72 h. (B) IFN-     production was determined by ELISA from supernatants of antigen-stimulated lymph node 
cells from PRAT4A  +/ −    or  PRAT4A  − / −    BM chimeric mice. Data are means + SD from each mouse, and the results of three independent mice per group are 
shown. Similar results were obtained in two independent experiments. (C) Serum was collected before (day 0) and after (day 8) immunization with OVA 
plus CFA, and the titers of OVA-specifi  c IgM, IgG2a/c, and IgG2b were determined by ELISA. Data are means + SD from three mice per group. Similar re-
sults were obtained in two independent experiments. *, P   <   0.01.     JEM VOL. 204, November 26, 2007 
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was informative about many aspects of TLR maturation, as well 
as traffi   cking within and display on immune cells. Moreover, 
we were able to categorize particular cellular responses to 
TLR ligands according to their dependence on PRAT4A. 
  PRAT4A is required for cell-surface expression of the 
Toll family of receptors and a related molecule, RP105. No 
abnormalities were found in cell-surface expression of non-
TLR molecules, including CD11c, CD11b, CD14, B220, 
MHC class I, CD19, IgM, IgD, and others in PRAT4A    −  /  −    
immune cells. Importantly, PRAT4A was not required for an-
tigen receptor expression and function, because PRAT4A    −  /  −    
B cells developed normally and responded to BCR-mediated 
signaling (  Fig. 3 B  ). In this regard, PRAT4A is distinct from 
gp96, which was reported to chaperone Ig (  17  ). Although gp96 
is a general chaperone, PRAT4A seems to be more dedicated to 
TLRs in immune cells. Immature glycosylation of cell-surface 
TLRs such as TLR1 and TLR4 in PRAT4A knockdown cells 
suggests an important role for PRAT4A in TLR protein mat-
uration in the ER (  Figs. 4 C   and S2 C) (  12  ). Consequently, 
TLR2/4 responses were impaired in PRAT4A    −  /  −    BM-DCs, 
macrophages, and B cells (  Figs. 1  –  3  ). 
  PRAT4A is also required for intracellular nucleic acid  –
  sensing TLR7/9. ER-resident TLR9 does not require matu-
ration of   N  -linked oligosaccharide in the Golgi apparatus. 
Nonetheless, TLR9 was unable to traffi   c to the endosome/
lysosome during ligand stimulation in PRAT4A knockdown 
cells (  Fig. 4 D  ). Given that the TLR9 ligand CpG is seques-
tered to lysosomes, TLR9 is unlikely to interact with its li-
gand DNA in the absence of PRAT4A. As a result, TLR9 
responses and signaling were completely abolished (  Figs. 1  –  5  ). 
TLR7 responses were impaired as much as TLR9 responses in 
PRAT4A    −  /  −    BM-DCs, BM-macrophages, and splenic B cells 
(  Figs. 1  –  3  ). Although TLR7 has not been reported to relocate 
upon ligand stimulation, the roles of PRAT4A for TLR7 are 
probably similar to those for TLR9. In this regard, TLR3 
seemed to be diff  erent from TLR7/9. Although poly(I:C) stim-
ulates both TLR3 and cytoplasmic sensors such as melanoma 
diff  erentiation-associated gene 5 or retinoic acid  –  inducible 
gene I (  18  ), mice lacking TLR3 were shown to be impaired 
in poly(I:C)-induced production of RANTES and IFN-     by 
macrophages and in CD86 up-regulation on B cells (  19, 20  ). 
Given that mice lacking PRAT4A were not impaired in these 
responses to poly(I:C), PRAT4A is unlikely to be required 
for TLR3. 
  Complementation with PRAT4A deletion mutants re-
vealed that the C-terminal 19 aa including the putative ER 
retention signal (PDEL) was not required for TLRs. We pre-
viously reported that TLR4 was still associated with PRAT4A 
mutants lacking PDEL or the C-terminal 19 aa (Del-1 and -2) 
(  21  ). As long as PRAT4A is associated with TLRs, the ER 
retention signal may not be so important. Further study with 
more deletion mutants is needed to understand the mecha-
nisms by which PRAT4A interacts with TLRs. 
  Dependency on PRAT4A seems to vary among TLRs and 
cell types. Although TLR7/9 responses were completely de-
pendent on PRAT4A, TLR2/4 responses were still detectable 
stimulation with a variety of TLR ligands. We found sig-
nifi  cant down-regulation of PRAT4A mRNA upon stimu-
lation with TLR ligands, whereas gp96, another chaperone 
required for multiple TLRs, was not down-regulated at all 
(Fig. S7, available at http://www.jem.org/cgi/content/full/
jem.20071132/DC1). These results suggest a regulatory role 
for PRAT4A in immune responses. 
    DISCUSSION   
  Successful targeting of the PRAT4A gene revealed that the 
corresponding protein is required for many TLR-dependent 
functions and has the potential for coordinating innate and adap-
tive immune responses. Characterization of the knockout mice 
  Figure 8.     PRAT4A    −  /  −    BM chimeric mice are resistant to LPS-in-
duced sepsis. (A) PRAT4A   − / −    ( n   = 10), PRAT4A  +/ −    ( n   = 5), and PRAT4A  +/+  
(  n   = 5) BM chimeric mice were administered with 400  –  500     g LPS intra-
peritoneally, and the mortality was shown as the percentage of survival. 
(B) Blood samples from PRAT4A  +/ −    ( n   = 6) and PRAT4A   − / −    ( n   = 6) mice 
were collected from the vena cava at 0 (no treatment), 1, 3, and 6 h after 
injection of a lethal dose of LPS (500     g per mouse). The concentrations 
of TNF-    , IL-6, IL-12, and RANTES were determined by ELISA. Data repre-
sent the SD. *, P   <   0.01.     2974 A MECHANISM REGULATING MULTIPLE TLRS | Takahashi et al.
(  Fig. 7  ). Impaired Th1-dependent responses were reported in 
mice lacking MyD88 (  27, 28  ). PRAT4A    −  /  −    BM-DCs were 
normal with respect to CD86 up-regulation upon lipid A 
stimulation and TLR3-dependent responses, both of which 
are MyD88 independent. Collectively, TLR signaling without 
PRAT4A may be shifted to MyD88-independent responses, 
suggesting an unexpected link between the subcellular distri-
bution of TLRs and their downstream signaling pathways. 
PRAT4A may have a role in determining the balance between 
MyD88 and MyD88-independent immune responses against 
a pathogen. 
  Another change in in vivo immune responses was re-
vealed in the LPS-induced sepsis model. PRAT4A    −  /  −    mice 
were resistant to the LPS-induced sepsis model (  Fig. 8 A  ). 
LPS-induced cytokine production in vivo was partially but 
signifi  cantly reduced (  Fig. 8 B  ). It is not clear whether such 
partial impairment in cytokine production was responsible 
for resistance against LPS-induced sepsis. Mice treated with 
lethal doses of LPS succumbed at latencies of up to 4 d (  Fig. 
8 A  ), long after serum TNF-     and IL-12 returned to basal 
levels (  Fig. 8 B  ), suggesting that mediators other than these 
cytokines might contribute to LPS-induced sepsis. In this re-
gard, high-mobility group box 1 (HMGB-1) has been shown 
to serve as a late mediator in sepsis (  29  ). HMGB-1 has been 
shown to act on TLRs (  30  ). It is interesting to study whether 
PRAT4A    −  /  −    cells are impaired in their secretion of or re-
sponsiveness to HMGB-1. PRAT4A might have a role in 
detrimental immune responses in LPS-induced sepsis. In this 
regard, it is of note that PRAT4A mRNA was down-regu-
lated after responses to a variety of TLR ligands (Fig. S7). 
PRAT4A mRNA down-regulation might have a role in lim-
iting innate immune responses. 
  Molecular pathways for responses to highly purifi  ed micro-
bial/viral products have been extensively studied, and there 
is clearly more to learn from that type of experimentation. 
However, a given immunocyte utilizes combinations of recep-
tors to simultaneously recognize multiple ligands, and there must 
be mechanisms to ensure that the corresponding response is 
appropriate. Further studies on PRAT4A would cast light on 
such mechanisms. 
  MATERIALS AND METHODS 
  Generation of PRAT4A    −  /  −     mice and immunizations.     PRAT4A    −  /  −    
mice were generated at Unitech. In brief, the targeting vector was con-
structed to replace the exon 1 with the neomycin resistance gene (Fig. S1). 
The targeting vector was transfected by electroporation of C57BL/6 embry-
onic stem (ES) cells. After selection with G418, ES clones were subject to 
PCR analyses and Southern blotting to identify homologous recombinant 
clones. Recombinant ES cells were microinjected into C57BL/6 blastocysts 
to obtain chimeric mice, which were then mated to generate heterozygous 
and homozygous mice. BM chimeric mice were generated by transferring 
BM cells from PRAT4A  +/  −    or PRAT4A    −  /  −    mice into C57BL/6 mice (6  –  7 wk 
of age) that had been irradiated at 950 rad. BM chimeric mice were used 
6  –  10 wk after transfer. Chimerism was confi  rmed by down-regulated TLR2 
and RP105 on splenic B cells from PRAT4A    −  /  −    cells. 
  Chimeric mice were immunized via injections into each hind footpad 
with OVA emulsifi  ed 1:1 in CFA (Difco Laboratories). 8 d after immunization, 
the draining popliteal and inguinal lymph nodes were isolated, and serum 
in PRAT4A    −  /  −    immune cells. PRAT4A-independent TLR2/4 
signaling and responses were more evident in BM-DCs than 
in macrophages or splenic B cells (  Figs. 1  –  3 and 5 A  ). We pre-
viously reported PRAT4B as a molecule similar to PRAT4A 
in aa sequence and in physical association with TLR4 (  21  ). 
PRAT4B might be responsible for PRAT4A-independent 
TLR2/4 responses, particularly in BM-DCs. This possibility 
is currently being studied. 
  Despite that cell-surface TLR4 was not detectable on 
PRAT4A    −  /  −    BM-DCs (  Fig. 1 A  ), there were some responses 
to lipid A in PRAT4A    −  /  −    mice, and this was most evident in 
up-regulation of CD86 on BM-DCs (  Fig. 5 B  ), suggesting 
that intracellular TLR4 may still be able to sense LPS. TLR4 
was reported to reside in the Golgi apparatus in intestinal 
  epithelial cells and respond to internalized LPS (  22  ). LPS 
  internalization is dependent on cell-surface CD14 (  23  ). If 
PRAT4A-independent TLR4 responses are dependent on 
LPS internalization, PRAT4A-independent lipid A responses 
should not be detected in CD14-negative cells. Indeed, LPS-
induced up-regulation of CD86 was seen in PRAT4A    −  /  −    
BM-DCs but not in PRAT4A    −  /  −    B cells (  Figs. 3 and 5  ). 
LPS-induced up-regulation of CD86 in DCs or macrophages 
was shown to be dependent on MyD88-independent signal-
ing (  24  ), which induces IRF3 phosphorylation and IFN-     
production. Impaired but detectable phosphorylation of IRF3 
and IFN-     production was observed with PRAT4A    −  /  −    BM-
DCs (  Figs. 1 and 5  ). This was apparently suffi   cient for up-
regulation of a co-stimulatory molecule but not completely 
suffi   cient for production of MyD88-independent cytokines 
such as RANTES and IFN-    . As is the case with TLR9 (  25  ), 
the subcellular distribution of TLR4/MD-2 might infl  uence 
LPS responses. Further studies are needed to determine the 
site of LPS recognition in PRAT4A    −  /  −    cells. 
  Although TLR1 was not detectable on PRAT4A    −  /  −    BM-
DCs, TLR2 was still detectable (  Fig. 1 A   and not depicted). 
PCSK was shown to stimulate TLR2 in the absence of TLR1 
(  26  ). Interestingly, PCSK-dependent activation of extracellular 
signal-regulated kinase 1/2 and p38 was delayed in PRAT4A    −  /  −    
BM-DCs (  Fig. 5 A  ), suggesting a qualitative diff  erence be-
tween PRAT4A-dependent and -independent responses to 
PCSK. It is possible that only the TLR1-independent signaling 
pathway was activated in PRAT4A    −  /  −    BM-DCs. PRAT4A    −  /  −    
cells might reveal an as yet uncharacterized lipopeptide recog-
nition that is dependent on TLR2 but not TLR1. 
  Alteration in multiple TLR responses in PRAT4A    −  /  −    cells 
led to impaired cytokine production against bacteria in vitro 
and in vivo (  Fig. 6, A and C  ). Of particular interest, IL-12 
production in response to heat-killed bacteria was profoundly 
down-regulated in mice lacking PRAT4A    −  /  −   . In contrast, 
up-regulation of CD86 in response to heat-killed bacteria 
was normal in PRAT4A    −  /  −    BM-DCs (  Fig. 6 B  ). Profound 
defects in multiple TLR responses resulted in a change in 
adaptive immunity. Upon immunization with OVA mixed 
with bacteria-containing CFA, PRAT4A    −  /  −    BM chimeric 
mice failed to mount Th1 responses, as revealed by impaired 
production of IFN-     and OVA-specifi  c IgG2a/c antibody JEM VOL. 204, November 26, 2007 
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the manufacturer  ’  s instructions. Quantitative PCR analyses were performed 
using a PCR system (7300 Fast Real-Time PCR System; Applied Biosystems) 
with gene expression assays (TaqMan; Applied Biosystems) for mouse PRAT4A 
(Mm00511161) and IFN-     (Mm00439546). Each sample was normalized 
using TaqMan gene expression assays for mouse     -actin (Mm00607939). 
  Immunofl  uorescence.     Cells were plated on a glass-bottom dish (Matsu-
nami) and used for staining. In some experiments, CpG-rhodamine (Hokkaido 
System Science) was used to stimulate TLR9-GFP. Cells were fi  xed by 4% 
formaldehyde  –  BS for 10 min at room temperature and washed three times 
with PBS. To analyze the location of the TLR-GFP fusion proteins, cells were 
stained with biotinylated cholera toxin subunit B (Sigma-Aldrich), followed 
by streptavidin  –  Texas red (Invitrogen), LysoTracker green, or ER tracker red 
(Invitrogen). DsRed2-ER vector and DsRed-monomer-Golgi vector were 
purchased from Clontech Laboratories, Inc. TLR-GFP and markers were 
visualized with confocal microscopy (LSM5 PASCAL; Carl Zeiss, Inc.). 
  ELISA.     Cells were plated at 10  5   cells per well in 96-well plates and stimu-
lated with a variety of TLR ligands. After 24 h, supernatant was collected, 
and concentrations of TNF-    , IL-6, IL-12, and RANTES were determined by 
ELISA kits (R  &  D Systems). To measure OVA-specifi  c antibodies, 10     g/ml 
OVA was used to coat a microtiterplate, and bound Ig isotypes were detected 
with specifi  c secondary antibodies (horseradish peroxidase  –  conjugated goat 
anti  –  mouse IgM, IgG1, and IgG2c; SouthernBiotech). 
  Statistical analysis.     Data from triplicate samples were used for statistical 
analysis. Statistical signifi  cance was calculated by the Student  ’  s   t  -test. P   <   0.05 
was considered signifi  cant. 
  Online supplemental material.     Fig. S1 shows the strategy for the targeted 
disruption of the mouse PRAT4A gene. Fig. S2 shows that PRAT4A is 
  associated with TLR1 and is required for its cell-surface expression. Fig. S3 
shows the physical association between PRAT4A and TLR9. Fig. S4 shows 
the complementation of PRAT4A knockdown by PRAT4A overexpression 
in the RAW264.7 macrophage cell line. Fig. S5 shows the complementation 
of PRAT4A    −  /  −    DCs by retrovirus-mediated overexpression of PRAT4A. 
Fig. S6 shows the requirement for PRAT4A in cytokine production by BM-DCs 
against heat-killed   M. tuberculosis  . Fig. S7 shows down-regulation of PRAT4A 
mRNA upon stimulation by TLR ligands. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20071132/DC1. 
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was collected from the mice before (day 0) and after immunization. All animal 
experiments were conducted with the approval of the Animal Research 
Committee at the Institute of Medical Science at the University of Tokyo. 
  Reagents, cells, and mice.     Anti-Flag antibody and anti-Flag  –  agarose were 
purchased from Sigma-Aldrich. Anti-HA antibody was purchased from 
Roche. Anti-GFP antibody was purchased from Invitrogen. The antibodies for 
fl  ow cytometry (anti-TLR2, anti-CD14, anti-CD11c, and anti-CD86) were 
purchased from eBioscience. Rat anti  –  mouse TLR1 mAb (TR23, IgG2a/    ) 
was established in our laboratory by immunizing a rat with Ba/F3 cells express-
ing TLR1. The mAb was chosen that stained the line used for immunization 
but not the original Ba/F3 cells. pAb to mouse PRAT4A was established in 
our laboratory by immunizing a rabbit with the fusion protein in which ma-
ture mouse PRAT4A (aa 38  –  276) was fused with glutathione   S  -transferase. 
  Lipid A purifi  ed from   Salmonella minnesota   (Re-595) and LPS from 
  E. coli   (O55:B5) were purchased from Sigma-Aldrich. PCSK and FSL-1 were 
purchased from EMC Microcollections. CpG-B (TCCATGACGTTCCT-
GATGCT) and CpG-A (GGGGTCAACGTTGAGGGGGG) DNA were 
synthesized by Hokkaido System Science. Poly(I:C) and loxoribine (7-allyl-
7,8-dihydro-8-oxo-guanosine) were purchased from InvivoGen. 
  RAW264, Ba/F3, M12, A20, HEK293, and NIH3T3 cells were cul-
tured as previously described (  31  ). C57BL/6 mice were purchased from 
  Japan SLC Inc. and maintained in the animal facility at the Institute of Medical 
Science at the University of Tokyo. BM-DCs were prepared as previously 
described (  12  ). In brief, BM cells were plated at 10  6   cells per milliliter in 
24-well plates with 10% FCS  –  RPMI 1640 supplemented with 10 ng/ml of 
recombinant mouse GM-CSF (Genzyme). At day 7, cells were harvested 
and used for fl  ow cytometry. To enrich PRAT4A    −  /  −    DCs expressing 
PRAT4A, we used a retroviral vector with the neomycin resistance gene. 
BM was isolated from PRAT4A    −  /  −    or PRAT4A  +/+   mice that had been 
  injected intraperitoneally 4 d before with 5 mg 5-FU. After 48 h of culture, 
cells were transduced with retroviral supernatant on two successive days. 
  After the second transduction, cells were washed and cultured in the presence 
of GM-CSF. During DC induction, 400     g/ml neomycin was included to 
enrich DCs expressing shRNA. 
  Flow cytometry.     Cell-surface staining and analyses on a FACSCalibur 
(BD Biosciences) were previously described (  12  ). 
  Immunoprecipitation and immunoprobing.     Immunoprecipitation and 
immunoprobing were previously described (  12  ). The antibodies used for 
immunoprobing were anti-Flag (M2), anti-HA, and anti-GFP. The second 
antibodies were goat anti  –  mouse IgG  –  alkaline phosphatase conjugate, goat 
anti  –  rat IgG –  alkaline phosphatase conjugate (American Qualex), and goat anti – 
rabbit IgG  –  alkaline phosphatase conjugate (Bio-Rad Laboratories). 
  endoH and   N  -glycosidase assay.     Cells were lysed in 1% Triton X-100 
lysis buff  er. Lysates were incubated with anti-Flag (M2) or anti-GFP anti-
body-conjugated beads at 4  °  C for 2 h. Proteins were eluted and treated with 
endoH or   N  -glycosidase according to the manufacturer  ’  s instructions (New 
England Biolabs, Inc.). Samples were subjected to SDS-PAGE and immuno-
probing with anti-TLR4 or anti-GFP antibodies. 
  siRNA.     To inhibit mouse PRAT4A expression, we produced a retroviral 
vector (provided by H. Iba and T. Mizutani, The University of Tokyo, Tokyo, 
Japan) expressing shRNA, as previously described (  12  ). The target sequence 
was 5    -gagtttgaagaggtgattgag-3    . As a control, we used cells expressing an empty 
vector. For complementation of PRAT4A gene silencing, four silent muta-
tions were introduced in the target sequence, as indicated by underlining 
(5    -gagtt  c  ga  g  ga  a  gt  a  attgag-3    ). This PRAT4A mutant was cloned into a retro-
viral vector and transduced into RAW264 cells expressing shPRAT4A. 
  Quantitative RT-PCR.     Quantitative PCR was conducted as previously 
described (  12  ). In brief, 1     g of total RNA was reverse transcribed into 
complementary DNA using ReverTra Ace -    - (TOYOBO), according to 2976 A MECHANISM REGULATING MULTIPLE TLRS | Takahashi et al.
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